Trials / Recruiting
RecruitingNCT06326983
Opioid Sparing Anesthesia Care for Pediatric Patients Having Tonsil Surgery
Opioid Sparing Anesthesia Care for Pediatric Patients Having Tonsil Surgery; a Randomized, Controlled, Non-inferiority Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 58 (estimated)
- Sponsor
- Boston Children's Hospital · Academic / Other
- Sex
- All
- Age
- 3 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, randomized, controlled, non-inferiority study of patients undergoing tonsil surgeries at Boston Children's Hospital Waltham. The overall aim is to evaluate the efficacy of an opioid anesthetic plan (morphine, ketorolac, and acetaminophen versus an opioid sparing anesthetic plan (dexmedetomidine, ketorolac and acetaminophen) for perioperative analgesia and recovery time in patients undergoing tonsillectomies and tonsillotomies at Boston Children's Hospital Waltham. Secondary measures include rescue opioids administered in post-anesthesia care unit (PACU), re-operation secondary to bleeding, emergence delirium, post-operative nausea and vomiting, intraoperative hemodynamics, intraoperative vasopressor administration, and length of procedure.
Conditions
- Tonsillitis
- Post-operative Nausea and Vomiting (PONV)
- Emergence Delirium
- Opioid Analgesic Adverse Reaction
- Anesthesia
- Pain
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexmedetomidine | Dexmedetomidine (1mcg/kg bolus given intravenously at induction of anesthesia |
| DRUG | Acetaminophen | Acetaminophen (12.5mg/kg with a maximum dose of 1 gram given intravenously at induction of anesthesia). |
| DRUG | Ketorolac | Ketorolac 0.5mg/kg with a max dose of 30mg intravenously at the end of surgery. |
| DRUG | Morphine | Morphine (0.1mg/kg given intravenously at induction of anesthesia) |
Timeline
- Start date
- 2024-05-09
- Primary completion
- 2026-02-28
- Completion
- 2026-04-01
- First posted
- 2024-03-25
- Last updated
- 2026-01-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06326983. Inclusion in this directory is not an endorsement.